1534-1535 / 2063
EGFR inhibition + RCT in HNSCC
•
Other EGFR inhibitors
? CONCERT trials
•
CONCERT-1
•
Open-label RCT phase II trial, stage III and IV HNSCC
•
RCT (n=63) vs R
C
T + Panitumumab (n=87)
•
CONCERT-2
•
Open-label RCT phase II trial, stage III and IV HNSCC
•
RCT (n= 61) vs
RT
+ Panitumumab (n=90)